Tag: medtech
New Drug Application of Desidustat Tablets Accepted in China
Desidustat Tablets are novel, oral HIF-PHI for treating anaemia in non-dialysis adult chronic kidney disease patients. The Product is administrated orally, thus expecting to...
Breaking News
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
HONG KONG, China and WILMINGTON, Del., Apr 1, 2024 - (ACN Newswire) - China Medical System Holdings Limited (“CMS” or the “Group”) and Incyte (Nasdaq:INCY)...
Nilam Resources Announces Letter of Intent to Acquire 24,800 Bitcoin
Nilam Resources, Inc. has entered into a Letter of Intent (LOI) with Xyberdata Ltd to acquire 100% of the common stock of a special...
Jamie Metzl at the Global AI Show
DUBAI, Mar 25, 2024 - (ACN Newswire) - The Global AI Show is thrilled to announce Jamie Metzl, esteemed author, technology visionary, and healthcare...
Avantor Wins Five Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2024
SINGAPORE, Mar 21, 2024 - (ACN Newswire) - Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life...
Life Sciences Ontario (LSO) & Ontario Bioscience Innovation Organization (OBIO®) Celebrating Women Leaders Across Ontario’s Life Sciences Sector International Women’s Day – March 8th,...
TORONTO–(BUSINESS WIRE)–Today, women make up 50% of university students enrolled in STEM and health programs in Canada.1 Women identifying as visible minorities make up...
IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at...
Cross-Border Impact Ventures Exceeds $90 Million in Final Close of Its Women’s and Children’s Health Technology Fund
Women-owned impact venture capital firm has made five investments to date in technology companies focused on women’s, children’s, and adolescents’ health
TORONTO–(BUSINESS WIRE)–Cross-Border Impact Ventures...
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd
TOKYO and SEOUL, Jan 24, 2024 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer...
How AI Is Shaping the Bioprocessing Industry
Bioprocessing embraces finding medical solutions within live specimens, but that doesn’t mean technological incorporations like AI are out of the picture. Health experts quickly...
Xcellerant Ventures Ends First Year with 10th Investment, Leading CRISPR QC’s $10 Million Series A Round
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#CRISPR–Xcellerant Ventures is proud to announce its investment in CRISPR QC, the San Diego-based biotechnology company that has developed the world’s first...
Nanowear Announces FDA 510(k) Clearance for AI-enabled Continuous Blood Pressure Monitoring and Hypertension Diagnostic Management: SimpleSense-BP
Utilizing patented nanosensors fueling transformative AI, SimpleSenseTM, is the first wearable platform that enables physicians to securely and accurately offer patients full routine cardiopulmonary...
Olympus Named to Dow Jones Sustainability World Index for Three Consecutive Years
TOKYO, Dec 11, 2023 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer and more...
Latest Intelligence
